Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorMeirelles, Beatriz Barbosa-
dc.contributorPimentel, Vitor Paiva-
dc.contributorCruz, Adriana Inhudes Gonçalves da-
dc.contributorReis, Carla-
dc.contributorBanco Nacional de Desenvolvimento Econômico e Social (Brasil). Gabinete da Presidência. Departamento de Divulgação. Gerência de Editoração-
dc.identifierMEIRELLES, Beatriz Barbosa et al. Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 = Pharmaceutical biotechnology industrial development: an assessment of Brazil’s strategy from 2009 to 2019. BNDES Setorial, Rio de Janeiro, v. 26, n. 51, p. 7-75, mar. 2020.-
dc.description.abstractPharmaceutical biotechnology has created opportunities for the treatment of rare and complex diseases, and has become strategic for innovation policies worldwide, including Brazil. The Brazilian scientific vocation for molecular biology and genomics gave rise to several public policies to internalize specific productive capacity and advance the development of innovative products. The gradual incorporation of those drugs in the Unified Health System (SUS) reinforced the need to spread the use of biosimilars and internalize their production; thus, guaranteeing a stable offer at competitive prices. BNDES contributed to the formulation and application of these policies by financing productive plants and product development; BNDES also participated in collegiate bodies and published articles since 2009. This study aims to analyze the Bank's evolution, focusing on the following axes: public procurement, financing, and regulation.-
dc.publisherBanco Nacional de Desenvolvimento Econômico e Social-
dc.subjectBanco Nacional de Desenvolvimento Econômico e Social (Brasil) - Financiamento-
dc.subjectBrazilian Development Bank - Financing-
dc.subjectBNDES Funtec-
dc.subjectBNDES Profarma-
dc.subjectBNDES Support Program to Develop the Industrial Health Sector-
dc.subjectSistema Único de Saúde (Brasil)-
dc.subjectSistema Único de Saúde (Brazil)-
dc.subjectIndústria farmacêutica - Brasil - 2009-2019-
dc.subjectPharmaceutical industry - Brazil - 2009-2019-
dc.subjectBiotecnologia farmacêutica - Brasil - 2009-2019-
dc.subjectPharmaceutical biotechnology - 2009-2019-
dc.subjectPolítica industrial - Brasil - 2004-2014-
dc.subjectIndustrial policy - Brazil - 2004-2014-
dc.subjectPolítica pública-
dc.subjectPublic policy-
dc.subjectPesquisa e desenvolvimento-
dc.subjectResearch and development-
dc.titleBalanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019-
Appears in Collections:Produção BNDES - Artigos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.